Agilent Technologies Inc. (NYSE: A) reported revenue of $1.69 billion for the fourth quarter of 2023, down 8.7% on a reported basis
Agilent Technologies (A) Earnings: 4Q23 Key Numbers
Categories
Health Care
Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth
Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite an increase
Earnings Summary: Highlights of Catalent’s Q1 2024 results
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the first
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company focused on transforming biomedical inventions into cutting-edge therapies. The company develops novel therapies
Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research universities and
Earnings Summary: Henry Schein (HSIC) Q3 2023 financial results
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter
Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of
Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased
Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023. Revenue was
Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today. Total revenue rose 1% year-over-year to $2.53 billion. Revenues grew 3%
Gilead Sciences reports Q3 earnings. Here’s everything you need to know
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of 2023. Revenues
Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit. Third-quarter net
VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also
Earnings Summary: Highlights of IDEXX Laboratories’ Q3 2023 earnings
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, has reported financial results for the third quarter of 2023. The
REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third quarter of
Main highlights from Eli Lilly’s (LLY) Q3 2023 earnings results
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37% compared to
Cigna Group (CI) Q3 2023 Earnings: Key financials and quarterly highlights
The Cigna Group (NYSE: CI) reported third quarter 2023 earnings results today. Total revenues increased 8% to $49 billion compared to the same
Earnings Summary: A snapshot of IQVIA Holdings’ Q3 2023 results
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
CVS Health (CVS) Q3 2023 Earnings: Key financials and quarterly highlights
CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today. Total revenues increased 10.6% year-over-year to $89.8 billion. Net income
Key takeaways from Pfizer’s (PFE) Q3 2023 earnings results
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter of 2023.
AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company